uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Combined BET-bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Neuro-Oncology. (Swartling)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Neuro-Oncology. (Swartling)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Neuro-Oncology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Neuro-Oncology. (Swartling)
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
Keyword [en]
MYC, BET Bromodomains, Cyclin dependent kinases, Treatment, Medulloblastoma
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-300906OAI: oai:DiVA.org:uu-300906DiVA: diva2:952849
Available from: 2016-08-15 Created: 2016-08-15 Last updated: 2016-09-18
In thesis
1.
The record could not be found. The reason may be that the record is no longer available or you may have typed in a wrong id in the address field.

Open Access in DiVA

No full text

By organisation
Neuro-Oncology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 2 hits
ReferencesLink to record
Permanent link

Direct link